Ellevest, Inc. Xencor Inc Transaction History

Ellevest, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	SELL	$19.74 - $29.01 $2,487 - $3,655	-126 Reduced 80.77%	30 $1,000
Q1 2022 Apr 19, 2022	BUY	$26.68 - $41.63 $3,361 - $5,245	126 Added 420.0%	156 $4,000
Q4 2021 Jan 24, 2022	BUY	$33.67 - $43.44 $1,010 - $1,303	30 New	30 $1,000
Q3 2021 Oct 19, 2021	SELL	$30.65 - $35.68 $4,321 - $5,030	-141 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$34.33 - $44.68 $4,840 - $6,299	141 New	141 $5,000

199

73.7M

1.7K

4.2K

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $803M
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.